« Previous 123 Next »
Viewing Page 1 of 3 | Showing Results 1 - 10 of 23

One study, multiple immunotherapy combinations for hormone-receptor-positive, HER2-negative breast cancer

April 23, 2018

Women with metastatic hormone-receptor-positive, HER2-negative breast cancer who have progressed after treatment with a CDK4/6 inhibitor may qualify for a newly opened immunotherapy study at Providence Cancer Institute.

Providence Cancer Institute Expansion

April 17, 2018

See the KPTV Health Watch news story about Providence Cancer Institute expansion on the 11th floor of Providence's Robert W. Franz Cancer Center.

Features Dr. Kevin Olson and infusion nurse Brittany O'Connell from Providence Cancer Institute in Portland, Oregon.

New immunotherapy studies for people with advanced melanoma

April 02, 2018

More than 10 studies of investigational and FDA-approved immunotherapies for people with advanced melanoma are currently open at Providence Cancer Institute.

Transoral robotic surgery yields benefits for Providence throat cancer patients

March 12, 2018

A recent assessment of the first 170 throat-cancer patients treated with transoral robotic surgery followed by risk-adapted adjuvant therapy at Providence Cancer Institute offers compelling evidence in favor of this new treatment approach.

Providence Cancer Institute expands outpatient services

March 09, 2018

From groundbreaking research to innovative treatments to compassionate care, everything we do at Providence Cancer Institute is for you, our patients. That’s why we’re expanding and consolidating outpatient cancer services on the 11th floor of our Robert W. Franz Cancer Center at Providence Portland Medical Center.

Providence opens groundbreaking immunoradiotherapy clinical trial for patients with newly diagnosed head and neck cancer

March 08, 2018

Many clinical trials are open only to patients with metastatic disease. One of the translational research goals of the Providence Head and Neck Cancer Program is to bring immunotherapy into treatment earlier.

Anti-OX40 enhances immunity in some head and neck cancer patients

March 07, 2018

Anti-OX40, a novel immunotherapy engineered by researchers at Providence Cancer Institute, continues to show promise as a potentially powerful way to treat cancer.

Adoptive T-cell transfer study opens for head and neck cancer patients

March 05, 2018

Adoptive T-cell transfer therapy is emerging as one of the most effective treatments to date for people with advanced melanoma. Now this treatment is available to patients with advanced or recurrent head and neck cancers through a clinical trial at Providence Cancer Institute.

Oregonians Benefit From Providence Philanthropists

February 27, 2018
It was a year in the record books for Providence Foundations of Oregon in 2017. They raised more than $50 million - and received the single largest gift ever - marking the most successful fundraising year in the 35 year history of the Providence Foundations in Oregon.

Providence Wellness Watch: Breast Cancer Surgery

February 01, 2018

For breast cancer patients, choosing a breast cancer surgeon for care has important benefits. Learn more from Kristen Massimino, M.D., medical director of the Providence Breast Cancer Program.

« Previous 123 Next »
Viewing Page 1 of 3 | Showing Results 1 - 10 of 23